Immunopathogenesis and Treatment of Halothane Hepatitis

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical Immunotherapeutics

• Publication date

  1995-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03259273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Halothane Hepatotoxicity: Relation Between Metabolic Activation, Hypoxia, Covalent Binding, Lipid Peroxidation and Liver Cell Damage

  2007cited by this paper
• Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro

  2004cited by this paper
• Drug-induced hepatic injury.

  1997cited by this paper
• Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.

  1995cited by this paper
• Absence of antitrifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage

  1994cited by this paper
• Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.

  1994cited by this paper
• Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting.

  1994cited by this paper
• Clinical enflurane metabolism by cytochrome P450 2E1

  1994cited by this paper
• Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid.

  1994cited by this paper
• Formation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro.

  1994cited by this paper
• Generation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro.

  1993cited by this paper
• Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and Methoxyflurane

  1993cited by this paper
• Mechanisms of halothane toxicity: novel insights.

  1993cited by this paper
• Halothane metabolism: the dihydrolipoamide acetyltransferase subunit of the pyruvate dehydrogenase complex molecularly mimics trifluoroacetyl-protein adducts.

  1993cited by this paper
• Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase

  1993cited by this paper
• Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72.

  1993cited by this paper
• Hepatotoxicity of volatile anaesthetics.

  1993cited by this paper
• Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis.

  1993cited by this paper
• Immunity to Halothane Metabolite‐Modified Proteins in Halothane Hepatitis a

  1993cited by this paper
• Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis.

  1993cited by this paper
• Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis.

  1992cited by this paper
• The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats.

  1992cited by this paper
• The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane.

  1992cited by this paper
• Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene.

  1992cited by this paper
• Oxidative and reductive metabolism by cytochrome P450 2E1

  1992cited by this paper
• Anaesthesia-related liver disease.

  1992cited by this paper
• A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-alpha but has no activity.

  1991cited by this paper
• Hapten carrier conjugates associated with halothane hepatitis.

  1991cited by this paper
• Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.

  1991cited by this paper
• Antibodies raised against trifluoroacetyl-protein adducts bind to N-trifluoroacetyl-phosphatidylethanolamine in hexagonal phase phospholipid micelles.

  1991cited by this paper
• Even isoflurane

  1991cited by this paper
• Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.

  1991cited by this paper
• Halothane metabolism: Kupffer cells carry and partially process trifluoroacetylated protein adducts.

  1991cited by this paper
• Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane.

  1990cited by this paper
• Antibody Assays for the Detection of Patients Sensitized to Halothane

  1990cited by this paper
• Criteria of drug-induced liver disorders. Report of an international consensus meeting.

  1990cited by this paper
• The role off a stress protein in the development off a drug-induced allergic response

  1990cited by this paper
• Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins.

  1990cited by this paper
• Halothane Hepatitis in Children

  1990cited by this paper
• Influence of isoniazid, phenobarbital, phenytoin, pregnenolone 16-alpha carbonitrile, and beta-naphthoflavone on halothane metabolism and hepatotoxicity.

  1990cited by this paper
• Early indicators of prognosis in fulminant hepatic failure.

  1989cited by this paper
• Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

  1989cited by this paper
• The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity.

  1989cited by this paper
• Human liver microsomal cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity.

  1989cited by this paper
• Detection of antibodies to a halothane metabolite hapten in sera from patients with halothane-associated hepatitis.

  1989cited by this paper
• Enflurane Metabolism Produces Covalently Bound Liver Adducts Recognized by Antibodies from Patients with Halothane Hepatitis

  1988cited by this paper
• Mechanism of halothane‐induced liver injury: Is it immune or metabolic idiosyncrasy?

  1988cited by this paper
• Evidence for expression in human liver of halothane‐induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis

  1988cited by this paper
• Halothane hepatitis patients generate an antibody response toward a covalently bound metabolite of halothane.

  1988cited by this paper
• Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane.

  1988cited by this paper
• I‐653 Resists Degradation in Rats

  1988cited by this paper
• Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.

  1988cited by this paper
• Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.

  1988cited by this paper
• Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis.

  1987cited by this paper
• Halothane hepatotoxicity in Fischer 344 rats pretreated with isoniazid.

  1987cited by this paper
• Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis.

  1987cited by this paper
• Characterization of a halothane-induced humoral immune response in rabbits.

  1987cited by this paper
• Halothane hepatitis: attempt to develop an animal model.

  1987cited by this paper
• Halothane Hepatitis Without Halothane: Role of Inappropriate Circuit Contamination and Its Prevention

  1986cited by this paper
• Multivariate analysis of prognostic factors in fulminant hepatitis B

  1986cited by this paper
• Effects of anticonvulsant agents on halothane‐induced liver injury in human subjects and experimental animals

  1986cited by this paper
• Halothane hepatitis. Detection of a constitutional susceptibility factor.

  1985cited by this paper
• Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.

  1985cited by this paper
• Halothane hepatitis without halothane: Role of inapparent circuit contamination and its prevention

  1985cited by this paper
• Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes.

  1985cited by this paper
• An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens.

  1984cited by this paper
• Halothane anaesthesia and liver damage.

  1984cited by this paper
• Specific serological markers in the diagnosis of fulminant hepatic failure associated with halothane anaesthesia.

  1983cited by this paper
• Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity.

  1983cited by this paper
• Enflurane hepatotoxicity. A clinicopathologic study of 24 cases.

  1983cited by this paper
• The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.

  1982cited by this paper
• Hypoxia Per Se Can Produce Hepatic Damage without Death in Rats

  1982cited by this paper
• Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.

  1982cited by this paper
• A perspective on halothane-induced hepatotoxicity.

  1982cited by this paper
• Suicidal inactivation of microsomal cytochrome P-450 by halothane under hypoxic conditions.

  1982cited by this paper
• Hepatic damage after exposure to halothane in medical personnel.

  1981cited by this paper
• Halothane hepatitis in three pairs of closely related women.

  1981cited by this paper
• Clinical Characteristics and Biotransformation of Sevoflurane in Healthy Human Volunteers

  1981cited by this paper
• Microsomal enzyme induction after halothane anaesthesia.

  1981cited by this paper
• Factors Affecting the Formation of Chlorotrifluoroethane and Chlorodifluoroethylene from Halothane

  1981cited by this paper
• Microsomal enzyme induction after halothane anaesthesia [letter]

  1981cited by this paper
• Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane.

  1980cited by this paper
• Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane.

  1980cited by this paper
• Occupational Exposure to Halothane Results in Enzyme Induction in Anesthetists

  1980cited by this paper
• Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.

  1980cited by this paper
• Halothane‐induced Hepatic Necrosis in Triiodothyronine‐pretreated Rats

  1980cited by this paper
• Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity.

  1980cited by this paper
• An Animal Model of Halothane Hepatotoxicity: Roles of Enzyme Induction and Hypoxia

  1979cited by this paper
• A prospective study of liver enzyme and other changes following repeat administration of halothane and enflurane.

  1979cited by this paper
• Sensitisation to Halothane-Altered Liver Components in Severe Hepatic Necrosis after Halothane Anaesthesia

  1979cited by this paper
• Volatile Metabolites and Decomposition Products of Halothane In Man

  1979cited by this paper
• Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines.

  1978cited by this paper
• Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia.

  1978cited by this paper
• Biological Reactive Intermediates III

  1977cited by this paper
• The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450.

  1977cited by this paper
• Biotransformation and hepatotoxicity of halothane.

  1977cited by this paper
• ANAEROBIC RELEASE OF FLUORIDE FROM HALOTHANE. RELATIONSHIP TO THE BINDING OF HALOTHANE METABOLITIES TO HEPATIC CELLULAR CONSTITUENTS

  1977cited by this paper
• Halothane Hepatotoxicity: Enhancement by Polychlorinated Biphenyl Pretreatment

  1977cited by this paper
• Pathological parasites in food handlers

  1976cited by this paper
• An Animal Model of Hepatotoxicity Associated with Halothane Anesthesia

  1976cited by this paper

• Increased serum anti-CYP2E1 IgG autoantibody levels may be involved in the pathogenesis of occupational trichloroethylene hypersensitivity syndrome: a case–control study

  2022influential citation
• Drug-induced liver injury

  2019cites this paper
• Sex Differences in Metabolism of Trichloroethylene and Trichloroethanol in Guinea Pigs

  2013cites this paper
• Mechanism, Pathology, and Clinical Presentation of Hepatotoxicity of Anesthetic Agents

  2013cites this paper
• A Review of its Pharmacodynamic and Pharmacokinetic Properties and its Clinical Use in General Anaesthesia

  2012cites this paper
• Chapter 25 – Drug-Induced Liver Injury

  2012cites this paper
• Drug‐Induced Liver Injury

  2011cites this paper
• Sevoflurane

  1996cites this paper